{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:08:49Z","timestamp":1791403729853,"version":"4.3.3"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Laboratory and Clinical Medicine"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.lab.2004.03.014","type":"journal-article","created":{"date-parts":[[2004,7,13]],"date-time":"2004-07-13T15:02:11Z","timestamp":1089730931000},"page":"31-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["The ratio of plasma to whole-blood serotonin may be a novel marker of atherosclerotic cardiovascular disease"],"prefix":"10.1016","volume":"144","author":[{"given":"Katsuko","family":"Hara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Hirowatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamichi","family":"Yoshika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Komiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Tsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakuo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3 part 2","key":"10.1016\/j.lab.2004.03.014_BIB1","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0002-8703(84)90669-0","article-title":"Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years","volume":"108","author":"Neaton","year":"1984","journal-title":"Am Heart J"},{"key":"10.1016\/j.lab.2004.03.014_BIB2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/01.CIR.0000019884.36724.D9","article-title":"Metabolic syndrome","volume":"106","author":"Reaven","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.lab.2004.03.014_BIB3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/bmj.325.7355.56","article-title":"Primary prevention of coronary heart disease","volume":"325","author":"Brindle","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.lab.2004.03.014_BIB4","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1046\/j.1365-2362.1996.2360585.x","article-title":"Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease","volume":"26","author":"Murakami","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.lab.2004.03.014_BIB5","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1159\/000064282","article-title":"Platelet activation markers in patients with nephrotic syndrome. a comparative study of different platelet function tests","volume":"91","author":"Sirolli","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.lab.2004.03.014_BIB6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ajh.10097","article-title":"A reliable plasma marker of platelet activation","volume":"70","author":"Gurney","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.lab.2004.03.014_BIB7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/jcp.24.3.250","article-title":"An assessment of platelet aggregation induced by 5-hydroxytryptamine","volume":"24","author":"Hilton","year":"1971","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.lab.2004.03.014_BIB8","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1248\/bpb.25.584","article-title":"Functional characterization of serotonin receptors in rat isolated aorta","volume":"25","author":"Villazon","year":"2002","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.lab.2004.03.014_BIB9","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/01.RES.64.5.900","article-title":"Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis","volume":"64","author":"Shimokawa","year":"1989","journal-title":"Circ Res"},{"key":"10.1016\/j.lab.2004.03.014_BIB10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1042\/cs0860269","article-title":"Plasma levels of 5-hydroxytryptamine during sympathetic stimulation and in Raynaud's phenomenon","volume":"86","author":"Coffman","year":"1994","journal-title":"Clin Sci (London)"},{"key":"10.1016\/j.lab.2004.03.014_BIB11","first-page":"9","article-title":"Serotonin as a factor involved in pathophysiology of thromboangiitis obliterans","volume":"12","author":"Pietraszek","year":"1993","journal-title":"Int Angiol"},{"key":"10.1016\/j.lab.2004.03.014_BIB12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0020-7292(01)00467-2","article-title":"Serotonin in pre-eclampsia","volume":"75","author":"Laskowska","year":"2001","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.lab.2004.03.014_BIB13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00001721-200107000-00009","article-title":"Effects of sarpogrelate hydrochloride on adenosine diphosphate\u2013 or collagen-induced platelet responses in arteriosclerosis obliterans","volume":"12","author":"Nakamura","year":"2001","journal-title":"Blood Coagul Fibrinol"},{"key":"10.1016\/j.lab.2004.03.014_BIB14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0049-3848(96)00212-5","article-title":"The effect of a 5HT2 receptor antagonist sarpogrelate (MCI-9042) treatment on platelet function in Buerger's disease","volume":"84","author":"Rydzewski","year":"1996","journal-title":"Thromb Res"},{"key":"10.1016\/j.lab.2004.03.014_BIB15","first-page":"19","article-title":"Effect of long-term ketanserin treatment on 5-HT levels, platelet aggregation and peripheral circulation in patients with Raynaud's phenomenon. A double-blind, placebo-controlled cross-over study","volume":"7","author":"Arneklo-Nobin","year":"1988","journal-title":"Int Angiol"},{"key":"10.1016\/j.lab.2004.03.014_BIB16","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1067\/mhj.2002.124056","article-title":"Effectiveness of a novel serotonin blocker, sarpogrelate, for patients with angina pectoris","volume":"144","author":"Kinugawa","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.lab.2004.03.014_BIB17","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/01.CIR.73.3.572","article-title":"Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries","volume":"73","author":"Ashton","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.lab.2004.03.014_BIB18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0167-5273(01)00517-4","article-title":"Urinary excretion of biopyrrins, oxidative metabolites of bilirubin, increases after spasm provocation tests in patients with coronary spastic angina","volume":"80","author":"Morita","year":"2001","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.lab.2004.03.014_BIB19","first-page":"14","article-title":"Shape and functional properties of human platelets washed with acid citrate","volume":"10","author":"Patsheke","year":"1981","journal-title":"Haemostasis"},{"key":"10.1016\/j.lab.2004.03.014_BIB20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1039\/an9931800165","article-title":"High-performance liquid chromatographic determination of 5-hydroxyindole by post-column fluorescence derivatization","volume":"118","author":"Ishida","year":"1993","journal-title":"Analyst"},{"issue":"suppl 5","key":"10.1016\/j.lab.2004.03.014_BIB21","first-page":"S6","article-title":"Platelet-derived serotonin, the endothelium, and cardiovascular disease","volume":"17","author":"Vanhoutte","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.lab.2004.03.014_BIB22","first-page":"386","article-title":"5-Hydroxytryptamine evokes endothelial nitric oxide synthase activation in bovine aortic endothelial cell cultures","volume":"221","author":"McDuffie","year":"1999","journal-title":"Proc Soc Exp Biol Med"},{"issue":"suppl 5","key":"10.1016\/j.lab.2004.03.014_BIB23","first-page":"S1","article-title":"Effects of serotonin on platelets and blood vessels","volume":"17","author":"De Clerck","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.lab.2004.03.014_BIB24","first-page":"1157","article-title":"Serotonin uptake in subpopulations of normal human blood platelets","volume":"17","author":"Arora","year":"1982","journal-title":"Biol Psychiatr"},{"key":"10.1016\/j.lab.2004.03.014_BIB25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0002-9149(97)00379-2","article-title":"Role of endothelial dysfunction in coronary artery disease","volume":"79","author":"Abrams","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.lab.2004.03.014_BIB26","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0735-1097(96)00221-5","article-title":"Nitroglycerin-induced coronary vasodilation is not enhanced in patients with impaired endothelium-dependent dilation","volume":"28","author":"Anderson","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lab.2004.03.014_BIB27","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0735-1097(00)00583-0","article-title":"Effects of bradykinin on coronary blood flow and vasomotion in transplant patients","volume":"35","author":"Aptecar","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lab.2004.03.014_BIB28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0049-3848(01)00333-4","article-title":"Enhanced platelet aggregation in the coronary circulation after coronary spasm","volume":"103","author":"Miyamoto","year":"2001","journal-title":"Thromb Res"},{"key":"10.1016\/j.lab.2004.03.014_BIB29","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1055\/s-0037-1615110","article-title":"Detection of platelets activated during acetylcholine-induced coronary vasospasm","volume":"79","author":"Inoue","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lab.2004.03.014_BIB30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/clc.4960190606","article-title":"Increased serotonin release across the coronary bed during a nonischemic interval in patients with vasospastic angina","volume":"19","author":"Murakami","year":"1996","journal-title":"Clin Cardiol"}],"container-title":["Journal of Laboratory and Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022214304000915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022214304000915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:35:09Z","timestamp":1758303309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022214304000915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0022214304000915"],"URL":"https:\/\/doi.org\/10.1016\/j.lab.2004.03.014","relation":{},"ISSN":["0022-2143"],"issn-type":[{"value":"0022-2143","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ratio of plasma to whole-blood serotonin may be a novel marker of atherosclerotic cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Laboratory and Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lab.2004.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}